Stock Movers: KB Home, Tesla Sales, and Cassava Sciences Slump

KB Home's Disappointing Quarter

• 🏠 KB Home reported disappointing first-quarter results, leading to a cut in its fiscal 2025 revenue guidance.
• 📉 Demand during the crucial spring selling season was more muted than historical levels, impacting the company's sales goals.
• ⚠️ High interest rates and affordability issues are cited as primary reasons for the subdued demand in the homebuilding sector.
• 💰 Builders are implementing incentives like mortgage rate buy-downs, which, while boosting sales, are weighing on profit margins.

Tesla's European Sales Decline

• 🚗 Tesla sales in Europe have fallen for the tenth time in the last twelve months.
• 📉 This decline is attributed to factors including production pauses for a model changeover and rising competition, particularly from Chinese manufacturers.
• 🗣️ While Elon Musk's political stances may play a role, competition and production issues are highlighted as more fundamental problems affecting sales.
• 💡 The company is counting on a redesigned Model Y to help turn around its sales performance.

Cassava Sciences Alzheimer's Program Discontinued

• 🔬 Cassava Sciences (SAVA) shares experienced their largest one-day drop on record.
• 💔 This slump follows the announcement that the company will discontinue its Alzheimer's treatment program with simufilam.
• 📊 The decision comes after a late-stage trial failure, where the treatment did not meet key endpoints for reducing cognitive or functional decline in patients.